CBX3/HP1γ is upregulated in tongue squamous cell carcinoma and is associated with an unfavorable prognosis

Zhang,Huayong; Fu,Xiaoyan; Su,Xuan; Yang,Ankui

doi:10.3892/etm.2018.5969

CBX3/HP1γ is upregulated in tongue squamous cell carcinoma and is associated with an unfavorable prognosis

Authors:
- Huayong Zhang
- Xiaoyan Fu
- Xuan Su
- Ankui Yang
View Affiliations

Affiliations: Department of Head and Neck Surgery, Sun Yan‑sen University Cancer Centre, Guangzhou, Guangdong 510000, P.R. China
Published online on: March 20, 2018 https://doi.org/10.3892/etm.2018.5969
Pages: 4271-4276
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Increased expression of CBX3/HP1γ, a core component of heterochromatin protein 1, has recently proved to be involved in human tumorigenesis and patient prognosis. The present study aimed to investigate the expression of CBX3/HP1γ and its clinicopathological significance in primary tongue squamous cell carcinoma (TSCC). Gene expression profiles of CBX3/HP1γ in TSCC from Oncomine database were analyzed. The expression of CBX3/HP1γ at protein level was measured using immunohistochemistry (IHC). The potential associations between CBX3/HP1γ expression and multiple clinicopathological parameters were estimated using the Chi square test. In addition, the effect of CBX3/HP1γ expression on patients' survival was further assessed by Kaplan‑Meier and Cox regression analyses. The agreement of elevated CBX3/HP1γ expression was indicated in four datasets on the Oncomine database. Aberrant overexpression of CBX3/HP1γ was identified in TSCC tissues compared with cancer‑adjacent normal tissue, which was significantly associated with cervical nodes metastasis (P=0.010) and clinical stage (P=0.025). Furthermore, patients with high CBX3/HP1γ expression exhibited a reduced survival compared with those with low expression (Log‑rank test, P=0.004). Univariate and multivariate Cox regression analysis suggested that the expression status of CBX3/HP1γ could be regarded as an independent prognostic factor for TSCC patients (HR=2.461; 95% CI=1.128‑5.370; P=0.024). The present study indicated that aberrant overexpression of Cbx3/HP1γ was associated with cervical nodes metastasis and unfavorable survival in TSCC. These findings suggest that CBX3/HP1γ may serve an important role in tongue tumorigenesis and may be a valuable candidate diagnostic and prognostic marker for TSCC patients.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
2	Chi AC, Day TA and Neville BW: Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Cancer J Clin. 65:401–421. 2015. View Article : Google Scholar : PubMed/NCBI
3	Duz MB, Karatas OF, Guzel E, Turgut NF, Yilmaz M, Creighton CJ and Ozen M: Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: A pilot study. Cell Oncol (Dordr). 39:187–193. 2016. View Article : Google Scholar : PubMed/NCBI
4	Li Z, Wang Y, Qiu J, Li Q, Yuan C, Zhang W, Wang D, Ye J, Jiang H, Yang J and Cheng J: The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer. Oncotarget. 4:2532–2549. 2013. View Article : Google Scholar : PubMed/NCBI
5	Canzio D, Larson A and Narlikar GJ: Mechanisms of functional promiscuity by HP1 proteins. Trends Cell Biol. 24:377–386. 2014. View Article : Google Scholar : PubMed/NCBI
6	Yuan C, Li Z, Qi B, Zhang W, Cheng J and Wang Y: High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer. J Oral Pathol Med. 44:159–165. 2015. View Article : Google Scholar : PubMed/NCBI
7	Fan Y, Li H, Liang X and Xiang Z: CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle. Oncotarget. 8:19934–19946. 2017.PubMed/NCBI
8	Minc E, Courvalin JC and Buendia B: HP1gamma associates with euchromatin and heterochromatin in mammalian nuclei and chromosomes. Cytogenet Cell Genet. 90:279–284. 2000. View Article : Google Scholar : PubMed/NCBI
9	Slezak J, Truong M, Huang W and Jarrard D: HP1γ expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy. BMC Cancer. 13:1482013. View Article : Google Scholar : PubMed/NCBI
10	Takanashi M, Oikawa K, Fujita K, Kudo M, Kinoshita M and Kuroda M: Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cance. Am J Pathol. 174:309–316. 2009. View Article : Google Scholar : PubMed/NCBI
11	Zhou J, Bi H, Zhan P, Chang C, Xu C, Huang X, Yu L, Yao X and Yan J: Overexpression of HP1γ is associated with poor prognosis in non-small cell lung cancer cell through promoting cell survival. Tumour Biol. 35:9777–9785. 2014. View Article : Google Scholar : PubMed/NCBI
12	Edge SB and Compton CC: The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI
13	Zheng X, Jia B, Lin X, Han J, Qiu X, Chu H, Sun X, Hu W, Pan J, Chen J and Zhao J: FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma. Int J Mol Med. 38:1443–1449. 2016. View Article : Google Scholar : PubMed/NCBI
14	Talbot SG, Estilo C, Maghami E, Sarkaria IS, Pham DK, O-charoenrat P, Socci ND, Ngai I, Carlson D, Ghossein R, et al: Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. Cancer Res. 65:3063–3071. 2005. View Article : Google Scholar : PubMed/NCBI
15	Estilo CL, O-charoenrat P, Talbot S, Socci ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y, Boyle JO, et al: Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer. 9:112009. View Article : Google Scholar : PubMed/NCBI
16	Kuriakose MA, Chen WT, He ZM, Sikora AG, Zhang P, Zhang ZY, Qiu WL, Hsu DF, McMunn-Coffran C, Brown SM, et al: Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci. 61:1372–1383. 2004. View Article : Google Scholar : PubMed/NCBI
17	Ye H, Yu T, Temam S, Ziober BL, Wang J, Schwartz JL, Mao L, Wong DT and Zhou X: Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics. 9:692008. View Article : Google Scholar : PubMed/NCBI
18	Suvà ML, Riggi N and Bernstein BE: Epigenetic reprogramming in cancer. Science. 339:1567–1570. 2013. View Article : Google Scholar : PubMed/NCBI
19	Zeng W, Ball AR Jr and Yokomori K: HP1: Heterochromatin binding proteins working the genome. Epigenetics. 5:287–292. 2010. View Article : Google Scholar : PubMed/NCBI
20	Maison C and Almouzni G: HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol. 5:296–304. 2004. View Article : Google Scholar : PubMed/NCBI
21	Bártová E, Malyšková B, Komůrková D, Legartová S, Suchánková J, Krejčí J and Kozubek S: Function of heterochromatin protein 1 during DNA repair. Protoplasma. 254:1233–1240. 2017. View Article : Google Scholar : PubMed/NCBI
22	Dialynas GK, Vitalini MW and Wallrath LL: Linking heterochromatin protein 1 (HP1) to cancer progression. Mutat Res. 647:13–20. 2008. View Article : Google Scholar : PubMed/NCBI
23	Saini V, Hose CD, Monks A, Nagashima K, Han B, Newton DL, Millione A, Shah J, Hollingshead MG, Hite KM, et al: Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma. PLoS One. 7:e414012012. View Article : Google Scholar : PubMed/NCBI
24	Lomberk G, Bensi D, Christensen T, Salisbury J and Urrutia R: HP1 γ has a significant impact on cell cycle progression through the regulation of G2/M, centrosome biology and, chromosomal stability in pancreatic cancer cells. Pancreas. 35:4122007. View Article : Google Scholar
25	Liu M, Huang FF, Zhang D, Ju J, Wu XB, Wang Y, Wang Y, Wu Y, Nie M, Li Z, et al: Heterochromatin protein HP1γ promotes colorectal cancer progression and is regulated by miR-30a. Cancer Res. 75:4593–4604. 2015. View Article : Google Scholar : PubMed/NCBI
26	Scully C and Bagan J: Oral squamous cell carcinoma overview. Oral Oncol. 45:301–308. 2009. View Article : Google Scholar : PubMed/NCBI
27	González-Ramírez I, Soto-Reyes E, Sánchez-Pérez Y, Herrera LA and García-Cuellar C: Histones and long non-coding RNAs: The new insights of epigenetic deregulation involved in oral cancer. Oral Oncol. 50:691–695. 2014. View Article : Google Scholar : PubMed/NCBI
28	Mascolo M, Siano M, Ilardi G, Russo D, Merolla F, De Rosa G and Staibano S: Epigenetic disregulation in oral cancer. Int J Mol Sci. 13:2331–2353. 2012. View Article : Google Scholar : PubMed/NCBI
29	Nestorov P, Tardat M and Peters AH: H3K9/HP1 and Polycomb: two key epigenetic silencing pathways for gene regulation and embryo development. Curr Top Dev Biol. 104:243–291. 2013. View Article : Google Scholar : PubMed/NCBI
30	Eguchi T, Calderwood SK, Takigawa M, Kubota S and Kozaki KI: Intracellular MMP3 promotes HSP gene expression in collaboration with chromobox proteins. J Cell Biochem. 118:43–51. 2017. View Article : Google Scholar : PubMed/NCBI
31	Hu H, Wang Y, Li Z, Zhu Y, Zhang W, Wang D, Lin T, Yang J, Wang Y and Cheng J: Overexpression of suppressor of zest 12 is associated with cervical node metastasis and unfavorable prognosis in tongue squamous cell carcinoma. Cancer Cell Int. 17:262017. View Article : Google Scholar : PubMed/NCBI
32	Sun M, Ha N, Pham DH, Frederick M, Sharma B, Naruse C, Asano M, Pipkin ME, George RE and Thai TH: Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells. Sci Rep. 7:428882017. View Article : Google Scholar : PubMed/NCBI